| Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a … T Pillinger, RA McCutcheon, L Vano, Y Mizuno, A Arumuham, G Hindley, ... The Lancet Psychiatry 7 (1), 64-77, 2020 | 823 | 2020 |
| The clinical significance of duration of untreated psychosis: an umbrella review and random‐effects meta‐analysis OD Howes, T Whitehurst, E Shatalina, L Townsend, EC Onwordi, ... World Psychiatry 20 (1), 75-95, 2021 | 185 | 2021 |
| The efficacy and heterogeneity of antipsychotic response in schizophrenia: a meta-analysis RA McCutcheon, T Pillinger, Y Mizuno, A Montgomery, H Pandian, ... Molecular psychiatry 26 (4), 1310-1320, 2021 | 86 | 2021 |
| Shared and separate patterns in brain morphometry across transdiagnostic dimensions RA McCutcheon, T Pillinger, X Guo, M Rogdaki, G Welby, L Vano, ... nature mental health 1 (1), 55-65, 2023 | 9 | 2023 |
| An automatic analysis framework for FDOPA PET neuroimaging G Nordio, R Easmin, A Giacomel, O Dipasquale, D Martins, S Williams, ... Journal of Cerebral Blood Flow & Metabolism 43 (8), 1285-1300, 2023 | 8 | 2023 |
| Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data S Siafis, V Chiocchia, MR Macleod, C Austin, A Homiar, F Tinsdeall, ... Wellcome open research 9, 182, 2024 | 5 | 2024 |
| Digital data repository and automatic analysis framework for FDOPA PET neuroimaging G Nordio, R Easmin, A Giacomel, O Dipasquale, D Martins, S Williams, ... Biorxiv, 2022.04. 14.488129, 2022 | 4 | 2022 |
| Magnitude and variability of structural brain abnormalities in neuropsychiatric disease: protocol for a network meta-analysis of MRI studies R McCutcheon, T Pillinger, G Welby, L Vano, C Cummings, X Guo, ... BMJ Ment Health 24 (3), 111-114, 2021 | 4 | 2021 |
| Neuromelanin-sensitive MRI: a biomarker for treatment-resistant schizophrenia? LJ Vano, M Veronese, RA McCutcheon, OD Howes American Journal of Psychiatry 181 (6), 468-470, 2024 | 2 | 2024 |
| Mesostriatal Dopaminergic Circuit Dysfunction in Schizophrenia: A Multimodal Neuromelanin-Sensitive Magnetic Resonance Imaging and [18F]-DOPA Positron Emission Tomography Study LJ Vano, RA McCutcheon, G Rutigliano, SJ Kaar, V Finelli, G Nordio, ... Biological Psychiatry 96 (8), 674-683, 2024 | 1 | 2024 |
| Effect of Ulotaront on Brain Dopamine Synthesis Capacity in Subjects With Schizophrenia on Stable Doses of a D2 Antipsychotic: Results of an 18F-DOPA Pet Study O Howes, L Vano, G Rutigliano, R McCutcheon, R Lew, S Milanovic, ... Neuropsychopharmacology 48, 387-388, 2023 | | 2023 |
| THE EFFICACY AND HETEROGENEITY OF ANTIPSYCHOTIC RESPONSE IN SCHIZOPHRENIA: A META-ANALYSIS R McCutcheon, T Pillinger, Y Mizuno, A Montgomery, H Pandian, L Vano, ... SCHIZOPHRENIA BULLETIN 46, S248-S249, 2020 | | 2020 |
| P. 155 The efficacy and heterogeneity of antipsychotic response in schizophrenia: a meta-analysis R McCutcheon, T Pillinger, Y Mizuno, A Montgomery, H Pandian, L Vano, ... European Neuropsychopharmacology 29, S121, 2019 | | 2019 |
| Клиническое значение длительности нелеченного психоза: зонтичный обзор и метаанализ случайных эффектов OD Howes, T Whitehurst, E Shatalina, L Townsend, EC Onwordi, ... | | |
| The effects of antipsychotic treatment on metabolic function: a systematic review and network meta-analysis T Pillinger, R McCutcheon, L Vano, K Beck, G Hindley, A Arumuham, ... | | |
